The burden of illness and economic evaluation for COPD

Ramsey S.D., Sullivan S.D.

Source: Eur Respir J 2003; 21: 29S-35S
Journal Issue: June 2003 - Suppl. 41
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ramsey S.D., Sullivan S.D.. The burden of illness and economic evaluation for COPD. Eur Respir J 2003; 21: 29S-35S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A national study of medical care expenditures for respiratory conditions
Source: Eur Respir J 2002; 19: 414-421
Year: 2002



Persistent asthma: disease control, resource utilisation and direct costs
Source: Eur Respir J 2002; 20: 260-267
Year: 2002



Factors influencing duration of exposure with symptoms and costs of occupational asthma
Source: Eur Respir J 2010; 36: 728-734
Year: 2010



Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs
Source: Eur Respir J 2004; 23: 304-309
Year: 2004



The cost of asthma to patient quality of life and the health service
Source: Eur Respir J 2005; 26: Suppl. 49, 672s
Year: 2005

Health care costs associated with acute asthma: a economic analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002

An outreaching model of tertiary difficult asthma care reduces adverse asthma outcomes and healthcare utilisation costs
Source: Eur Respir J 2016; 47:1857-1860
Year: 2016


The cost-effectiveness of smoking cessation interventions. Accounting for medical costs in longer life expectancies
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


Enhanced care review for people with COPD in primary care addressing quality, cost-effectiveness and productivity
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012


Severe COPD: assessment of impairment, quality of life and burden on health care resources
Source: Annual Congress 2004 - PG4 - Management of end-stage patients with COPD
Year: 2004


The clinical and economic impact of the combined interventions of telehealth, specialist respiratory nursing care and health coaching interventions for COPD admissions within an urban setting
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
Source: Eur Respir J, 52 (5) 1801363; 10.1183/13993003.01363-2018
Year: 2018



Health care cost associated with acute and stable asthma: an economic analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 418s
Year: 2003

Does introduction of a home oxygen service lead to healthcare cost savings?
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Financial impact of COPD on long-term disability pension programs
Source: Eur Respir J 2003; 22: Suppl. 45, 217s
Year: 2003

Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study
Source: Eur Respir J, 55 (5) 1901139; 10.1183/13993003.01139-2019
Year: 2020



Societal costs of severe asthma in Sweden
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018